Xcout Intel
Vigil Neuroscience, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Vigil Neuroscience, Inc. among biotechnology companies — ranked by similarity to what Vigil Neuroscience, Inc. actually does, not by market-cap band.
Subscribe to see Vigil Neuroscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Vigil Neuroscience, Inc.
Vigil Neuroscience is a biotechnology company headquartered in Massachusetts that harnesses the power of microglia for the treatment of neurodegenerative diseases.
Vigil Neuroscience, Inc. at a glance
Vigil Neuroscience, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $40M in April 2025. Xcout tracks 1 named person at Vigil Neuroscience, Inc., including Ivana Magovcevic-Liebisch (President and Chief Executive Officer).
Vigil Neuroscience, Inc. leadership
- Ivana Magovcevic-LiebischPresident and Chief Executive Officer
Vigil Neuroscience, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $40M | 14 named | |
| IPO | $40M | 6 named | |
| Series B | $90M | 14 named | |
| SEC Form D filing | $75M | — | |
| SEC Form D filing | $90M | — | |
| — | $50M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Vigil Neuroscience, Inc. competitors
Ranked by semantic similarity — how close each company is to Vigil Neuroscience, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Myrobalan Therapeutics is a pre-clinical biotechnology company headquartered in Medford, Massachusetts, focused on developing oral small molecule therapies for central nervous system and neurodegenerative diseases. The company targets novel mechanisms to create neurorestorative treatments for CNS disorders.
Similar biotechnology company
AstronauTx is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2019, the firm develops novel small-molecule drugs aimed at treating neurodegenerative conditions such as Alzheimer's disease by targeting glial cell dysfunction.
Similar biotechnology company
Delix Therapeutics is a privately held biopharmaceutical company headquartered in Boston, Massachusetts, focused on transforming the treatment of brain health through neuroscience.
Similar biotechnology company
Alzheon, Inc. is a clinical-stage biopharmaceutical company headquartered in Framingham, Massachusetts. Founded in 2013, the company is dedicated to developing a broad portfolio of investigational therapeutic products for neurodegenerative disorders, including Alzheimer's disease. Its research centers on advancing disease-modifying treatments for patients with cognitive decline.
Similar biotechnology company
FoldLogic Bio is a clinical-stage biotechnology company developing targeted immunotherapies for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple System Atrophy. The company focuses on modulating the central nervous system's immune responses, specifically targeting microglial activity, alpha-synuclein, and TREM2 to halt disease progression.
Similar biotechnology company
Nido Biosciences, Inc. is a clinical-stage holding and biotechnology company headquartered in Watertown, Massachusetts. The company focuses on discovering and advancing treatments for debilitating neurological diseases, including the development of targeted drugs.
Similar biotechnology company
Prevail Therapeutics Inc. is a biotechnology company headquartered in New York City, New York, focused on developing gene therapies for patients with neurodegenerative diseases.
Similar biotechnology company
Atalanta Therapeutics is a biotechnology company headquartered in Boston, Massachusetts, focused on developing RNA-interference therapeutic interventions for neurodegenerative diseases. The company launched with significant venture backing from life sciences investors.
Biotech
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.
Similar biotechnology company
Cerevance is a pharmaceutical and biotechnology research company based in Boston, Massachusetts, that uses its proprietary NETSseq platform to develop cell-type specific treatments. The company focuses on neurodegenerative, psychiatric, and central nervous system-controlled metabolic disorders.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Similar biotechnology company
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Vigil Neuroscience, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vigil Neuroscience, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →